PharmiWeb.com - Global Pharma News & Resources

General - Press Releases

Date Title Company
13-Nov-2023 Abcuro Initiates Part B of Registrational Phase 2/3 MUSCLE Clinical Trial of Ulviprubart (ABC008) for the Treatment of Inclusion Body Myositis Businesswire
13-Nov-2023 Zura Bio Reports Third Quarter 2023 Financial Results and Recent Business Highlights Businesswire
13-Nov-2023 KalVista Pharmaceuticals Announces Phase 3 KONFIDENT Trial Milestone Achieved Businesswire
13-Nov-2023 Aurinia Pharmaceuticals Announces Collaboration Partner Otsuka Filed New Drug Application (NDA) for LUPKYNIS® (Voclosporin) in Japan Businesswire
13-Nov-2023 First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s) Businesswire
13-Nov-2023 PHC Corporation Announces that Indonesia-based Life Science Equipment Subsidiary Established in March by PHC Group Will Begin Full-scale Operations Businesswire
13-Nov-2023 Mauna Kea Technologies and Telix Pharmaceuticals to Expand Partnership in Uro-oncologic Surgery Businesswire
11-Nov-2023 Cleerly, Partners Announce TRANSFORM Trial to Evaluate Personalized Heart Disease Care Strategies at American Heart Association 2023 Businesswire
11-Nov-2023 INTEGRA DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Integra LifeSciences Holdings Corp. and Encourages Investors to Contact the Firm Businesswire
11-Nov-2023 Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Businesswire
11-Nov-2023 Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Fisker Inc. (FSR) on Behalf of Investors Businesswire
11-Nov-2023 Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of James River Group Holdings, Ltd. (JRVR) on Behalf of Investors Businesswire
11-Nov-2023 Recor Medical Announces U.S. Launch and First Commercial Cases of Paradise Ultrasound Renal Denervation Therapy Businesswire
10-Nov-2023 Over 5,000 Shareholders and Clients Attend 30th Annual Baron Investment Conference Businesswire
10-Nov-2023 New asundexian Phase III study to include patients with atrial fibrillation ineligible for oral anticoagulant treatment Businesswire
10-Nov-2023 Procaps Group to Report Third Quarter and Nine Months 2023 Results on Tuesday November 14, 2023 Businesswire
10-Nov-2023 PsychoGenics Launches an Updated Corporate Identity and Brand Businesswire
10-Nov-2023 Plastic Medical Transport Boxes Dominate the Market: Passive Cooling Technology Takes the Lead - ResearchAndMarkets.com Businesswire
10-Nov-2023 In Shocking Reversal, CMS Wants to Allow Medicare Part D Plan Sponsors to Substitute Non-Interchangeable Biosimilars Newswire
10-Nov-2023 Global Bio-acetic Acid Market Analysis Report 2023-2030: Growing Demand in the Pharmaceuticals Industry & Increasing Usage of Bio-based Vinyl Acetate Monomer - ResearchAndMarkets.com Businesswire